ID: ALA4541864

Max Phase: Preclinical

Molecular Formula: C12H8FN3

Molecular Weight: 213.22

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Fc1cnccc1-c1ccnc2[nH]ccc12

Standard InChI:  InChI=1S/C12H8FN3/c13-11-7-14-4-1-9(11)8-2-5-15-12-10(8)3-6-16-12/h1-7H,(H,15,16)

Standard InChI Key:  IKSVOVRMDGWNBK-UHFFFAOYSA-N

Associated Targets(Human)

7,8-dihydro-8-oxoguanine triphosphatase 280 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 213.22Molecular Weight (Monoisotopic): 213.0702AlogP: 2.76#Rotatable Bonds: 1
Polar Surface Area: 41.57Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 3.27CX LogP: 1.79CX LogD: 1.79
Aromatic Rings: 3Heavy Atoms: 16QED Weighted: 0.67Np Likeness Score: -0.92

References

1. Wiedmer L, Schärer C, Spiliotopoulos D, Hürzeler M, Śledź P, Caflisch A..  (2019)  Ligand retargeting by binding site analogy.,  175  [PMID:31077996] [10.1016/j.ejmech.2019.04.037]

Source